(Q28196624)

2

0 references

D Mark Pullan

3

0 references

Brian M Fabri

4

0 references

Walid C Dihmis

The Annals of Thoracic Surgery

5

0 references

language of work or name

English

0 references

publication date

July 2003

0 references

published in

0 references

volume

76

0 references

issue

1

0 references

page(s)

41-5

0 references

cites work

Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Aspirin in the Prevention of Coronary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Aspirin does not increase homologous blood requirements in elective coronary bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Limitations of the Parsonnet score for measuring risk stratified mortality in the north west of England. The North West Regional Cardiac Surgery Audit Steering Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Comparing apples and oranges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

The meaning and use of the area under a receiver operating characteristic (ROC) curve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Preoperative and immediate postoperative aspirin also reduces morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Reoperations for bleeding after coronary artery bypass procedures during 25 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6

Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900182-6